Sort   by:  
 Page size 
UnknownCOVID-19 vaccine dose sparing: strategies to improve vaccine equity and pandemic preparedness.
Not available
S-EPMC8923677 | biostudies-literature
UnknownWhat motivates SARS-CoV-2 vaccine trial participants? A pre- and post-participation survey study.
Not available
S-EPMC11539315 | biostudies-literature
UnknownAssessment of Risks Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Experimental Human Infection Studies.
Not available
S-EPMC7799229 | biostudies-literature
UnknownImmunological Considerations for Schistosoma Vaccine Development: Transitioning to Endemic Settings.
Not available
S-EPMC7970007 | biostudies-literature
UnknownPlasmodium falciparum Infection of Human Volunteers Activates Monocytes and CD16+ Dendritic Cells and Induces Upregulation of CD16 and CD1c Expression.
Not available
S-EPMC4534665 | biostudies-literature
UnknownChemically Enhanced Immunogenicity of Bacteria by Supramolecular Functionalization with an Adjuvant.
Not available
S-EPMC10098600 | biostudies-literature
UnknownEthical and practical considerations arising from community consultation on implementing controlled human infection studies using Schistosoma mansoni in Uganda.
Not available
S-EPMC9258062 | biostudies-literature
UnknownCyclodextrin/Adamantane-Mediated Targeting of Inoculated Bacteria in Mice.
Not available
S-EPMC8028042 | biostudies-literature
UnknownDynamics of the bacterial gut microbiota during controlled human infection with Necator americanus larvae.
Not available
S-EPMC7714523 | biostudies-literature
UnknownScreening of a Library of Recombinant Schistosoma mansoni Proteins With Sera From Murine and Human Controlled Infections Identifies Early Serological Markers.
Not available
S-EPMC9016452 | biostudies-literature
Sort   by:  
 Page size